Yuan Jian

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Computed Tomography

Ejection Fraction

Multiple Myeloma

Patient Reported

Top Venues

Cancer medicine

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Yuan Jian, Feifei Han, Ying Zhu, Chuanying Geng, Yanru Zhang, Yin Wu, Yun Leng, Wenming Chen, Zhuoling An, Hong-Hu Zhu
Paired comparisons of venetoclax concentration in cerebrospinal fluid, bone marrow, and plasma in acute leukemia patients. Clinical and translational science 17 (9) (2024)
Yuan Jian, Long Chang, Ming-Xia Shi, Ying Sun, Xiao-Xia Chu, Hua Xue, Wen-Rong Huang, Xu-Liang Shen, Jie Ma, Guo-Rong Jia, Ya-Qing Feng, Zhen-Fang Xi, Yan-Hong Zhao, Yan-Ping Ma, Jing Xiao, Guang-Yu Ma, Qing-Ming Wang, Li Bao, Yu-Jun Dong, He-Bing Zhou, Chunyan Sun, Guo-Hong Su, Yan Yan, Sai-Yin Qimuge, Li-Ping Su, Jing-Nan Sun, Wei-Wei Tian, Xiu-Li Sun, Hong-Mei Jing, Da Gao, Wen-Ming Chen, Jian Li, Wen Gao
Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairment. Blood advances (2023)
Huixing Zhou, Yuan Jian, Juan Du, Junru Liu, Zhi-Yao Zhang, Guangzhong Yang, Guorong Wang, Ying Tian, Yanchen Li, Yin Wu, Wenming Chen, Weijun Fu, Juan Li, Wen Gao
Prognostic nomogram for multiple myeloma early relapse after autologous stem cell transplant in the novel agent era. Cancer medicine (2023)
Yuan Jian, Huixing Zhou, Yidan Wang, Zhi-Yao Zhang, Guangzhong Yang, Chuanying Geng, Ying Tian, Wen Gao, Wenming Chen
Echocardiography-defined pulmonary hypertension is an adverse prognostic factor for newly diagnosed multiple myeloma patients. Cancer medicine 11 (22) (2022)
Wen Gao, Yuan Jian, Juan Du, Xiaozhe Li, Huixing Zhou, Zhi-Yao Zhang, Guangzhong Yang, Guorong Wang, Ying Tian, Yanchen Li, Yin Wu, Weijun Fu, Juan Li, Wenming Chen
Gain of 1q21 is an adverse prognostic factor for multiple myeloma patients treated by autologous stem cell transplantation: A multicenter study in China. Cancer medicine 9 (21) (2020)